C31H43NO10
Neat
589.7
-20°C
Room Temperature
Norbuprenorphine Glucuronide; Norbuprenorphine 3-glucuronide; UNII-YPZ2R0PR50; YPZ2R0PR50; Norbuprenorphine 3-beta-D-Glucuronide; beta-D-Glucopyranosiduronic acid, (5alpha, 7alpha)-4, 5-epoxy-18, 19-dihydro-7-((1S)-1-hydroxy-1, 2, 2-trimethylpropyl)-6-methoxy-6, 14-ethenomorphinan-3-yl; NORBUPRENORPHINE 3-.BETA.-D-GLUCURONIDE; .BETA.-D-GLUCOPYRANOSIDURONIC ACID, (5.ALPHA., 7.ALPHA.)-4, 5-EPOXY-18, 19-DIHYDRO-7-((1S)-1-HYDROXY-1, 2, 2-TRIMETHYLPROPYL)-6-METHOXY-6, 14-ETHENOMORPHINAN-3-YL; RefChem:166560; 469887-29-4; Norbuprenorphine 3-ss-D-Glucuronide; Norbuprenorphine 3-b-D-Glucuronide (~90%); Norbuprenorphine 3-?-D-Glucuronide; CHEBI:183937; DTXSID401023512; Norbuprenorphine 3-beta-D-Glucuronide (1mg/ml in Acetonitrile); Norbuprenorphine 3-beta-D-Glucuronide (1mg/ml in Acetonitrile) (DISCONTINUED); (2S, 3S, 4S, 5R, 6S)-3, 4, 5-trihydroxy-6-[[(1S, 2S, 6R, 14R, 15R, 16R)-16-[(2S)-2-hydroxy-3, 3-dimethylbutan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12, 8.01, 6.02, 14.012, 20]icosa-8(20), 9 and 11-trien-11-yl]oxy]oxane-2-carboxylic acid
(2S, 3S, 4S, 5R, 6S)-3, 4, 5-trihydroxy-6-[[(1S, 2S, 6R, 14R, 15R, 16R)-16-[(2S)-2-hydroxy-3, 3-dimethylbutan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12, 8.01, 6.02, 14.012, 20]icosa-8(20), 9 and 11-trien-11-yl]oxy]oxane-2-carboxylic acid
InChI=1S/C31H43NO10/c1-27(2,3)28(4,38)16-13-29-8-9-31(16,39-5)26-30(29)10-11-32-17(29)12-14-6-7-15(22(42-26)18(14)30)40-25-21(35)19(33)20(34)23(41-25)24(36)37/h6-7,16-17,19-21,23,25-26,32-35,38H,8-13H2,1-5H3,(H,36,37)/t16-,17-,19+,20+,21-,23+,25-,26-,28+,29-,30+,31-/m1/s1